PHARMAZEUTISCHE FORMULIERUNG

European patent · EP3720424 · In force

Register entry

Publication number
EP3720424
Application number
EP18811304
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 6, 2018
Published
Oct 14, 2020
Granted
Sep 21, 2022
Protection ends at the latest
Dec 5, 2038
Next annual fee due
Dec 31, 2026
IPC classes
A61K 9/28 (2006.01)
A61K 9/20 (2006.01)
A61K 31/5517 (2006.01)
Priority
EP 17206197 08.12.2017
PCT application
PCT/EP2018/083772 06.12.2018
PCT publication
WO2019/110723 13.06.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Aug 2, 2023

    Change

    Published in Swissreg on 02.08.2023

  5. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  6. Sep 21, 2022

    Granted

    Published in Swissreg on 21.09.2022

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

KNOBLOCH, Thomas Peter Wilhelm

4323 Wallbach

HUMMEL, Georg

4070 Basel

BUSSON, Patrick Jean-Marie

4070 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.